jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Oct. 20, 2016

Dec. 17, 2018

jRCT2080223352

Phase II study of BK1304 in healthy adults

version:
date:

The Research Foundation For Microbial Diseases Of Osaka University

06-6877-4812

600

Interventional

observer-blind

2

Written informed consent is obtained from subject

20age old over
64age old under

Both

Prevention of influenza

investigational material(s)
Generic name etc : BK1304
INN of investigational material :
Therapeutic category code : 631 Vaccines
Dosage and Administration for Investigational material : 2 doses of intranasal administration

Efficacy

Immunogenicity, Safety

The Research Foundation For Microbial Diseases Of Osaka University

JapicCTI-163407

History of Changes

No Publication date
6 Dec. 17, 2018 (this page) Changes
5 Aug. 03, 2018 Detail Changes
4 Aug. 03, 2018 Detail Changes
3 Oct. 24, 2016 Detail Changes
2 Oct. 20, 2016 Detail Changes
1 Oct. 20, 2016 Detail